Santen Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santen Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Ono Pharmaceutical Co Ltd
sales of 160.28 billion Japanese Yen [US$1.54 billion]
of which 31%
was Metabolic Medicine And Vitamin compound),
Nichi-Iko Pharmaceutical Company Limited
(143.51 billion Japanese Yen [US$1.38 billion]
of which 100%
was Ethical Pharmaceutical), and
Ohki Healthcare Holdings Co Ltd
(207.59 billion Japanese Yen [US$1.99 billion]
During the year ended March of 2016, sales at
Santen Pharmaceutical Company Limited were ¥195.29 billion (US$1.87 billion).
increase of 20.7%
versus 2015, when the company's sales were ¥161.83 billion.
This was the fifth consecutive year of sales increases at Santen Pharmaceutical Company Limited
(and since 2011, sales have increased a total of 76%).
Sales of Pharmaceutical Products saw an increase
20.9% in 2016, from
¥159.26 billion to ¥192.55 billion.